Product Images Drax Exametazime

This is a description of a medication kit for preparing Technetium Tc 99m Exametazime for Leukocyte Labeling for use in leukocyte labeling procedures. The kit contains five single-dose vials and is manufactured by Draximage Inc., located in Kirkland, Quebec, Canada. The medication should be stored between 15°C and 25°C and used quickly, and the labeling procedure requires the use of a gamma camera. The text appears to have been obtained from packaging or labeling materials.*

This is a package insert for Drax Exametazime, a kit used to prepare Technetium Tc 99m Exametazime for leukocyte labeling. It provides detailed instructions for the preparation of the solution and the labeling of leukocytes. The process involves reconstituting Bametazime, adding it to Exametazime, incubating the WBCs, and measuring radioactivity. The insert also includes a suggested measurement worksheet and contact information for Jubilant Draximage Inc.*

Drax Exametazime™ is a kit designed for the preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling. Part 1 of this kit involves leukocyte preparation, and detailed instructions can be found in the package insert. The process involves using a 60 mL syringe, a needle size of 19-20 gauge, an anticoagulant, and mixing gently for 2 minutes at an angle of 10°-20°. The process also involves sedimentation, transfer, and centrifugation. The remaining steps involve adding NaCl and multiple washings.*

This is a LOT# Drax Exametazime™ kit for the preparation of Technetium-99m Exametazime for leukocyte labeling. It is for intravenous use only and does not contain any antimicrobial preservative. It can be stored at 15°C - 25°C (50°Fto 77°F) before reconstitution and must be used within 30 minutes of reconstitution at 20°C - 25°C (68°F - 77°F) for labeling leukocytes. The concentration is not available.*

This is a description of the contents of a vial, which contains 0.5 mg of exametazime, a medication used in medical imaging, and 7.6 mcg of stannous chloride dihydrate. The stannous chloride has a minimum of 0.6 mcg of stannous tin and a maximum of 4 mcg of total stannous and stannic tin per vial. Additionally, the vial contains 4.5 mg of sodium chloride.*

Drax Exametazime is a diagnostic agent used for intravenous purposes after radiolabeling leukocytes. It is available in a single-dose vial with a strength of 0.5 mg/vial and is for prescription use only. Before reconstitution, it should be stored at 15°C - 25°C up to the expiry date while after reconstitution, it needs to be stored at 20°C - 25°C and can be used for labeling leukocytes within 30 minutes. Since it is radioactive material, usage, composition, reconstitution, and radiolabeling instructions should be followed and provided in the package insert. The manufacturer of the product is Jubilant Draximage Inc., based in Kirkland, Quebec, Canada.*

Diax Exametazie™ is a preparation of Technetum Tc 95 Exametazime for leukocyte labeling. The document provides instructions on how to calculate labeling efficiency using a gl stinge T 9melate and an assay on the ceriugadWECs. The text also provides information on how to assay i 99 Examtasine bSeOWECE and how to calculate labeling efficiency. At the end of the document, there is a signature by Dratnagelnc along with an address, however, it is not possible to read the full address due to errors.*

Drax Exametazine™ is used for Radiodhemical Pury Testing. The text also mentions a patent and a manufacturer, but additional information is not available due to incomplete text.*